[
    [
        {
            "time": "",
            "original_text": "医美股测评③｜华熙生物：新兴业务开拓受挫，多头白热化竞争成发展隐忧？",
            "features": {
                "keywords": [
                    "华熙生物",
                    "新兴业务",
                    "开拓受挫",
                    "多头竞争",
                    "发展隐忧"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医美股测评③｜华熙生物：新兴业务开拓受挫，多头白热化竞争成发展隐忧？",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "华东医药：为两家全资子公司提供合计不超过1.5亿美元担保 大额借贷担保",
            "features": {
                "keywords": [
                    "华东医药",
                    "全资子公司",
                    "担保",
                    "大额借贷"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华东医药：为两家全资子公司提供合计不超过1.5亿美元担保 大额借贷担保",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华东医药(000963.SZ)拟开展金融衍生品交易业务",
            "features": {
                "keywords": [
                    "华东医药",
                    "金融衍生品",
                    "交易业务"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华东医药(000963.SZ)拟开展金融衍生品交易业务",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]